fig1

Complete response with fotemustine and bevacizumab after early progression following radiotherapy and temozolomide treatment in patient with glioblastoma multiforme

Figure 1. (a) Magnetic resonance imaging 3 months after finishing radiotherapy during temozolomide monotherapy; (b) response after two cycles of fotemustine and bevacizumab treatment